A type 2 diabetes course that puts the Kazakhstan protocol next to ADA 2026
For teachers of internal medicine and endocrinology working with years 3–5 and first-year residents: a ready course that trains students to say which guideline a threshold comes from, with an opening that can be set as reading before the first class.
The course Type 2 Diabetes Mellitus: Pathogenesis, Diagnosis, Complications and Management is in the VARGATES Medical catalogue in English and, as a separate edition, in Russian. By its catalogue record it has 26 lessons and 141 minutes of study. Four content modules (epidemiology and pathogenesis, diagnosis, complications, principles of management) each hold five lessons and an eight-question checkpoint. The final assessment has 25 questions, a 75% pass mark and two attempts; at least a third of the questions analyse a generalised teaching case with no surname, date of birth or history traceable to a real clinic.
Three documents, read against each other
The course names its clinical basis with editions: the ADA Standards of Care in Diabetes—2026, the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in CKD, and the Kazakhstan Ministry of Health clinical protocol «Type 2 diabetes mellitus» No. 158 of 4 March 2022. Where they differ, the course shows the difference instead of averaging it. Its own example is the eGFR threshold for starting an SGLT2 inhibitor, which it describes as lower in KDIGO 2022 and ADA 2026 than in the 2022 protocol wording; a whole lesson in the management module is built on that comparison.
A second habit the course drills is keeping association apart from effect. It sets UKPDS 33, which reduced microvascular outcomes in newly diagnosed type 2 diabetes, beside EMPA-REG OUTCOME, which reduced cardiovascular death in people who already had cardiovascular disease, and asks students to keep the two populations and the two claims separate.
Fitting it into a teaching cycle
Set the first three lessons as reading before the first class: why the course exists and where its boundary lies, why a prevalence figure cannot be quoted from memory, and who is at risk. They open without an account; the rest of the course opens after registration, and students can enrol themselves.
Open each seminar with the checkpoint of the module the group has just finished: eight questions show where to start the discussion.
In the session on drug choice, take the lesson on KDIGO 2022 versus the 2022 protocol and ask each student to name both thresholds and the document behind each one.
Use the final assessment as the credit for the cycle, or give it to residents as a self-check before a ward rotation.
Plan other sessions for these topics
The course does not teach the management of type 1, gestational or monogenic diabetes as disciplines of their own, nor intensive care for diabetic comas, which the 2022 protocol sends to a separate document. It gives no universal doses and writes no individual prescriptions, and it has no separate module on type 2 diabetes in children and adolescents. Its sources are those in force when it was built, in September 2026.